Abstract 2063P
Background
In this study we seek to learn more about the lifestyle habits of our cancer patients, with a particular emphasis in exercise and eating behaviours. We choose to focus on these two areas as they have an outsized impact on clinical outcomes such as mortality, risk of relapse, quality of life, sarcopenia, duration of hospitalizations, post-surgical complications, response to immunotherapy and even overall survival rates.
Methods
Observational study across a cross-section of cancer patients at the Medical Oncology Service of the Nuestra Señora de Candelaria University Hospital, Santa Cruz de Tenerife. The statistical significance of lifestyle habit changes is tested through a form and IPAQ, MUST, and SARC-F surveys using chi-squared tests.
Results
We involved 100 patients whose average age was 61 years. 46% of patients had lung cancer, 30% breast cancer and 10% gastrointestinal cancer. 59% patients had stage-four cancer, 48% were receiving first-line treatment and 54% were being treated with immunotherapy or target therapies. 99% of individuals considered their diet as an important pillar in their cancer disease. However, we found that only 47% had discussed aspects of their nutrition with their oncologist, but this was not statistically associated with a reduced risk of malnutrition. 80% considered that a healthy lifestyle could help reduce the adverse effects of the treatment. The validated test results showed that 45% had an intermediate-high risk of malnutrition according to the MUST test and 14% had risk of sarcopenia according to the SARC-F test. Patients receiving immunotherapy or target therapies had a higher risk of malnutrition than those receiving other treatments (50 vs 42%, p=.507). 47% were sedentary according to the IPAQ test and 80% who did not perform physical activity would start an adapted exercise program if it were available.
Conclusions
Our patients present good high-level awareness about the generally positive ways in which lifestyle changes involving healthier eating and exercise habits can impact the outcome of their treatments. However, we appreciate a need for more specific nutritional and fitness recommendations that patients can immediately put into practice, as well their ranked impact on their health.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2096P - Morphine titration with intravenous patient-controlled analgesia for severe cancer pain (Mr.TIPS)
Presenter: Seok Jae Huh
Session: Poster session 06
2097P - Incidence, risk factors (RFs) and management of oral mucositis (OM) in patients (pts) treated with a fluoropyrimidines (FP)-based therapy (tp): A retrospective, monocentric experience
Presenter: Fiorella Manfredi
Session: Poster session 06
2098P - The impact of concomitant use of non-opioid analgesics and immune checkpoint inhibitors on survival in lung cancer patients: A Hong Kong population-based cohort study
Presenter: Zheng-Hao Ye
Session: Poster session 06
2099P - The role of ambulatory blood pressure measurement in TKI-induced arterial hypertension diagnosis
Presenter: Elina Khachaturian
Session: Poster session 06
2100P - An exploratory study of the efficacy and safety of hetrombopag in the treatment of thrombocytopenia induced by concurrent or sequential chemoradiotherapy
Presenter: Jun Wang
Session: Poster session 06
2101P - Bleeding Induced by ANtiCAncer drugs (BIANCA) used breast cancer
Presenter: Nicolas Janus
Session: Poster session 06
2102P - Changes in opioid usage after intrathecal morphine pump implantation in patients with terminal cancer (pilot study)
Presenter: Eun Joo Choi
Session: Poster session 06
2103P - Phase Ib, international, dose-escalation study to evaluate the safety, pharmacokinetics (PK) and efficacy of ST-617 a dithiolethione, for the attenuation of oral mucositis (OM) in patients receiving chemoradiation (CRT) for head & neck (H&N) cancer
Presenter: Daniel Osei-Fofie
Session: Poster session 06
2104P - Prevention of taxane chemotherapy induced nail changes and peripheral neuropathy by application of extremity cooling: A prospective single center study with intrapatient comparison
Presenter: Kristen Johnson
Session: Poster session 06
2105P - Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study
Presenter: Rita De Sanctis
Session: Poster session 06